Literature DB >> 25877806

Obstructive sleep apnoea and non-restorative sleep induced by the interface.

Michael Westhoff1, Patric Litterst2.   

Abstract

BACKGROUND: There are only few data about the influence of interfaces on restorative sleep and required CPAP/APAP levels in patients with obstructive sleep apnoea (OSA). Observations of obstructive apnoeas when using oro-nasal masks with normalisation of respiratory disturbance index (RDI) under nasal masks and of non-restorative sleep under oro-nasal masks in spite of normal RDI led to a registration of patients with such findings.
METHODS: This study is a cohort analysis (June 1, 2006 to April 30, 2014) of patients with OSA using an oro-nasal mask and normalisation of the RDI after changing to a nasal mask and of patients complaining about a non-restorative sleep under an oro-nasal mask despite normal RDI.
RESULTS: Sixty-five patients (BMI 32.2 ± 8.1 kg/m(2); 64.4 ± 12.8 years) with OSA (n = 54) and non-restorative sleep with normal RDI (n = 11) under oro-nasal masks were included. In the group of patients with pathologic RDI under oro-nasal masks (n = 54), switching the interface to a nasal mask normalised RDI (31.8 ± 16.3 to 6.0 ± 3.6/h [p < 0.001]) and arousal index (p < 0.001); slow-wave and REM sleep increased (p < 0.05). In the patient group with a pathological RDI under CPAP/APAP therapy (n = 45), the pressure decreased from 9.5 ± 2.2 to 7.3 ± 2.0 cm hPa (p < 0.001), and in the group with normal RDI (n = 11) from 10.1 ± 2.4 to 6.8 ± 1.2 hPa (p < 0.01).
CONCLUSION: The usage of an oro-nasal mask can result in a paradoxical induction of obstructive hypopnoeas or apnoeas. Clinicians should be aware of this phenomenon. When adapting patients to a PAP therapy, a nasal mask should be preferred even if patients report mouth breathing.

Entities:  

Keywords:  CPAP therapy; Full-face mask; Nasal mask; Non-restorative sleep; Obstructive sleep apnoea; Oro-nasal mask

Mesh:

Year:  2015        PMID: 25877806     DOI: 10.1007/s11325-015-1173-3

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  29 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Equivalence of nasal and oronasal masks during initial CPAP titration for obstructive sleep apnea syndrome.

Authors:  Ming Teo; Terence Amis; Sharon Lee; Karina Falland; Stephen Lambert; John Wheatley
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

3.  Continuous positive airway pressure delivered by oronasal mask may not be effective for obstructive sleep apnoea.

Authors:  Fabíola Schorr; Pedro R Genta; Marcelo G Gregório; Naury J Danzi-Soares; Geraldo Lorenzi-Filho
Journal:  Eur Respir J       Date:  2012-08       Impact factor: 16.671

Review 4.  Neural and anatomic factors related to upper airway occlusion during sleep.

Authors:  S T Kuna; J E Remmers
Journal:  Med Clin North Am       Date:  1985-11       Impact factor: 5.456

5.  [Influence of adaptive servoventilation on B-type natriuretic petide in patients with Cheyne-Stokes respiration and mild to moderate systolic and diastolic heart failure].

Authors:  M Westhoff; M Arzt; P Litterst
Journal:  Pneumologie       Date:  2010-04-26

6.  Upper airway pressure-flow relationships in obstructive sleep apnea.

Authors:  P L Smith; R A Wise; A R Gold; A R Schwartz; S Permutt
Journal:  J Appl Physiol (1985)       Date:  1988-02

7.  A randomized crossover efficacy trial of oral CPAP (Oracle) compared with nasal CPAP in the management of obstructive sleep apnea.

Authors:  Fiona E Anderson; Ruth N Kingshott; D Robin Taylor; David R Jones; Lewis R Kline; Kenneth F Whyte
Journal:  Sleep       Date:  2003-09       Impact factor: 5.849

8.  Evidence of interrelated side effects with reduced compliance in patients treated with nasal continuous positive airway pressure.

Authors:  Marcel A Baltzan; Osama Elkholi; Norman Wolkove
Journal:  Sleep Med       Date:  2008-03-07       Impact factor: 3.492

9.  Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of masks in patients with chronic hypercapnic respiratory failure.

Authors:  P Navalesi; F Fanfulla; P Frigerio; C Gregoretti; S Nava
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

10.  Influence of marital status and employment status on long-term adherence with continuous positive airway pressure in sleep apnea patients.

Authors:  Frédéric Gagnadoux; Marc Le Vaillant; François Goupil; Thierry Pigeanne; Sylvaine Chollet; Philippe Masson; Marie-Pierre Humeau; Acya Bizieux-Thaminy; Nicole Meslier
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more
  4 in total

1.  Obstructive sleep apnoea and non-restorative sleep induced by the interface.

Authors:  Cigdem Akyol Beyoglu; Antonio M Esquinas
Journal:  Sleep Breath       Date:  2015-10-19       Impact factor: 2.816

2.  Response to: Obstructive sleep apnoea and non-restorative sleep induced by the interface.

Authors:  Michael Westhoff; Patric Litterst
Journal:  Sleep Breath       Date:  2015-10-19       Impact factor: 2.816

3.  Choosing an Oronasal Mask to Deliver Continuous Positive Airway Pressure May Cause More Upper Airway Obstruction or Lead to Higher Continuous Positive Airway Pressure Requirements than a Nasal Mask in Some Patients: A Case Series.

Authors:  Justin R Ng; Vinod Aiyappan; Jeremy Mercer; Peter G Catcheside; Ching Li Chai-Coetzer; R Doug McEvoy; Nick Antic
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

Review 4.  Choosing the right interface for positive airway pressure therapy in patients with obstructive sleep apnea.

Authors:  Ahmed S BaHammam; Tripat Singh; Smitha George; Karen Lorraine Acosta; Kashmira Barataman; Divinagracia E Gacuan
Journal:  Sleep Breath       Date:  2017-03-29       Impact factor: 2.816

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.